Investors

Webcast ImageWebcast - Replay
Q4 2015 Array BioPharma Inc. Earnings Conference Call
08/03/15 at 9:00 a.m. ET
Profile

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (partnered with AstraZeneca).

Array BioPharma
Fact Sheet

Array BioPharma
2014 Annual Report

Stock Quote & Chart

ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.81
Change (%) Stock is Up 0.12 (2.11%)
Volume1,721,898
Data as of 08/04/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
 
Stock chart for: 03NA000000ARRY
Recent NewsMore >>

Upcoming Events

More >>
There are currently no events scheduled.
Primary IR Contacts
Tricia Haugeto
Director, Corporate Communications and Investor Relations
Phone: (303) 386-1193
E-mail: Tricia.Haugeto@arraybiopharma.com

Transfer Agent
American Stock Transfer and Trust Company
6201 15th Avenue
Brooklyn, NY 11219
Phone: (800) 937-5449
Fax: (718) 236-4588
E-mail: Info@amstock.com
Website: http://www.amstock.com

Legal
Gross Cutler Seiler Dupont LLC
1877 Broadway, Suite 601
Boulder, CO 80302
Phone: (303) 926-4823

Accountants
KPMG LLP
707 Seventeenth Street, Suite 2700
Denver, CO 80202
Phone: (303) 295-5572


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.